Trademark Overview
On Friday, March 15, 2024, a trademark application was filed for BREAKTHROUGH T1D with the United States Patent and Trademark Office. The USPTO has given the BREAKTHROUGH T1D trademark a serial number of 98451675. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, October 9, 2024. This trademark is owned by JDRF International. The BREAKTHROUGH T1D trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Charitable fundraising; online charitable fundraising; charitable fundraising services by means of organizing and conducting special events; charitable fundraising services by means of running and walking events; charitable fundraising services for promoting research and education relating to type 1 diabetes; charitable foundation services, namely, providing fundraising activities and investment management services to support type 1 diabetes research
Association services, namely, promoting the public interest and awareness of curing, treating, and preventing type 1 diabetes; promoting public awareness of type 1 diabetes, type 1 diabetes research, and treatments, preventions and cures for type 1 diabetes, by means of public advocacy
Providing information in the field of prevention, screening, diagnosis and treatment of type 1 diabetes; providing information in the field of prevention, screening, diagnosis and treatment of type 1 diabetes via a website; providing health information; providing health information in the field of type 1 diabetes
Providing information about medical research; providing information about medical research in the field of type 1 diabetes; Providing information about medical and scientific research via a website; Providing medical and scientific research information in the field of clinical trials; Providing an online database in the field of medical and scientific research as it relates to type 1 diabetes